ArticleBriefings in bioinformatics2023
Response to 'comment on rigorous benchmarking of T cell receptor repertoire profiling methods for cancer RNA sequencing' by Davydov A.N.; Bolotin D.A.; Poslavsky S. V. and Chudakov D.M.
Yu-Ning Huang, Mohammad Vahed, Kerui Peng, Houda Alachkar, Serghei Mangul
Abstract readComment
In one paragraphArticle in Briefings in bioinformatics, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
5 · Who and what moneyAuthors and funding
5 authors.
Yu-Ning HuangTitus Family Department of Clinical Pharmacy, Alfred E. Mann School of Pharmacy and Pharmaceutical Sciences, University of Southern California, Los Angeles, California, 90089, USA.
Mohammad VahedTitus Family Department of Clinical Pharmacy, Alfred E. Mann School of Pharmacy and Pharmaceutical Sciences, University of Southern California, Los Angeles, California, 90089, USA.
Kerui PengTitus Family Department of Clinical Pharmacy, Alfred E. Mann School of Pharmacy and Pharmaceutical Sciences, University of Southern California, Los Angeles, California, 90089, USA.
Houda AlachkarTitus Family Department of Clinical Pharmacy, Alfred E. Mann School of Pharmacy and Pharmaceutical Sciences, University of Southern California, Los Angeles, California, 90089, USA.
Serghei MangulTitus Family Department of Clinical Pharmacy, Alfred E. Mann School of Pharmacy and Pharmaceutical Sciences, University of Southern California, Los Angeles, California, 90089, USA.
Funding
Developing robust and scalable genomics tools and databases to analyze immune receptor repertoires across diverse populationsR01AI173172 · NIAID · UNIVERSITY OF SOUTHERN CALIFORNIA · PI ALACHKAR, HOUDA · 2023 to 2025
$2.5MLeveraging the TCR Repertoire to identify target neoantigens in FLT3-ITD positive Acute Myeloid LeukemiaR01CA248381 · NCI · UNIVERSITY OF SOUTHERN CALIFORNIA · PI ALACHKAR, HOUDA · 2021 to 2025
$1.8MNCI NIH HHS R01 CA248381NIAID NIH HHS R01 AI173172
6 · The paper itselfAbstract
PubMed holds no abstract for this paper.
Indexed as
BenchmarkingNeoplasmsHumansReceptors, Antigen, T-Cell, alpha-betaSequence Analysis, RNAT-LymphocytesReceptors, Antigen, T-Cell, alpha-betaBenchmarkingImmunogenomicsRNA sequencingT-cell receptorTCR sequencing
Identifiers
PMID37824736
PMCPMC10569746
What OpenQuestion holds
Textmetadata
LicenceCC BY-NC
Read underepoch 390